Unicycive Therapeutics Inc (UNCY) - News Archive

Unicycive Therapeutics Investors Urged to Act Amid Securities Fraud AllegationsIn recent developments, Rosen Law Firm, a prominent global investor rights law firm, is calling attention to potential securities fraud invo...

Unicycive Therapeutics, a biopharmaceutical company focused on developing breakthrough therapies, has announced the completion of its Phase 1 clinical study for UNI-494. The study demonstrated that UNI-494 is well-toler...

Unicycive Therapeutics Announces NDA Submission to U.S. FDA for Innovative Phosphate Binder Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company dedicated to the development of therapies f...

Unicycive Therapeutics, a clinical-stage biotechnology company, has recently released positive patient satisfaction findings from a pivotal clinical trial of Oxylanthanum Carbonate (OLC). Patients participating in the t...

Unicycive Therapeutics Joins Russell Microcap Index: A Promising Leap for Kidney Disease InnovatorLos Altos, Calif., July 1, 2024 Unicycive Therapeutics, Inc. (Nasdaq: UNCY) has announced its inclusion in the Russell Mi...

Efficacy and Safety of Oxylanthanum Carbonate: Results from a Pivotal Clinical Trial Unicycive Therapeutics Inc. recently concluded a pivotal clinical trial evaluating Oxylanthanum Carbonate (OLC), a drug formulated to...

:This article reviews the presentation by Unicycive Therapeutics on the bioequivalence of Oxylanthanum Carbonate (OLC) compared to Lanthanum Carbonate, delivered at the National Kidney Foundation Spring Clinical Meeting...

Unicycive Therapeutics to Showcase Innovative Therapies for Kidney Disease at European Renal Association CongressLOS ALTOS, Calif., March 25, 2024 Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a leading clinical-stage bi...

In an exciting move for Unicycive Therapeutics Inc, the company has recently announced a successful private placement that has secured $50 million in investment. This funding round was led by new investors Octagon Capit...

In the world of biopharmaceuticals, research and development efforts are constantly underway to address pressing medical needs and advance patient care. One such endeavor is currently being pursued by OLC, a leading pha...

Unicycive Therapeutics, a leading biopharmaceutical company, recently announced a significant step forward in the treatment of Chronic Kidney Disease (CKD) on dialysis. By enrolling the first patient in a pivotal clinic...